Citation Impact
Citing Papers
Anti-C5 Antibody Treatment Ameliorates Weakness in Experimentally Acquired Myasthenia Gravis
2007
Cochrane Database of Systematic Reviews
2003 Standout
Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals
1987
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
2009
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
Myasthenia Gravis
1988
Myasthenia Gravis
2016 Standout
Cytokines and the pathogenesis of myasthenia gravis
1997
Strategies for Treatment of Myasthenia Gravisa
1993
Anti‐MuSK patient antibodies disrupt the mouse neuromuscular junction
2008
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
Neurexin Iα Is a Major α-Latrotoxin Receptor That Cooperates in α-Latrotoxin Action
1998 StandoutNobel
Interaction of synaptotagmin with the cytoplasmic domains of neurexins
1993 StandoutNobel
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Regulatory T Cells
2000 StandoutNobel
Guillain-Barré syndrome
2016 Standout
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.
1991
Vagal control of lymphocyte release from rat thymus
1994
Guillain–Barré Syndrome
2012 Standout
Rebooting the Immune System with High‐Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis
2008
Therapeutic Uses of Botulinum Toxin
1991
The G Protein-coupled Receptor CL1 Interacts Directly with Proteins of the Shank Family
2000 StandoutNobel
An anti‐ganglioside antibody‐secreting hybridoma induces neuropathy in mice
2004
A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in ‘antibody-negative’ myasthenia gravis
1990
Myasthenia Gravis
1994 Standout
Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals
1998
Neurexins Are Functional α-Latrotoxin Receptors
1999 StandoutNobel
Anatomy of the antigenic structure of a large memberane autoantigen, the muscle‐type nicotinic acetylcholine receptor
1998
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
1993 StandoutNatureNobel
Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patients
1989
Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair
2010
α-Latrotoxin Receptor CIRL/Latrophilin 1 (CL1) Defines an Unusual Family of Ubiquitous G-protein-linked Receptors
1998 StandoutNobel
Immunotherapy in autoimmune neuromuscular disorders
2002
Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravisa
1987
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
α-latrotoxin and related toxins
1989
Autoimmune Disorders of Neuronal Potassium Channels
2003
Increased levels of acetylcholine receptor α‐subunit mRNA in experimental autoimmune myasthenia gravis
1988
Stabilization of acetylcholine receptors at the neuromuscular synapse: the role of the nerve
1992
Regulation of LNS Domain Function by Alternative Splicing: The Structure of the Ligand-Binding Domain of Neurexin Iβ
1999 StandoutNobel
T‐Helper Epitopes on Human Nicotinic Acetylcholine Receptor in Myasthenia Gravisa
1993
Adhesion receptors of the immune system
1990 StandoutNature
Myasthenia gravis
2019 Standout
Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study
1987
Humoral Pathogenesis of Myasthenia Grayisa
1987
Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis
1990
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor
2000
Mycophenolate Mofetil in the Therapy of Severe Myasthenia gravis
2001
How myasthenia gravis alters the safety factor for neuromuscular transmission
2008
Anti-GQ1b Ganglioside Antibody in Peripheral Nervous System Disorders
2004
Neural regulation of mRNA for the α-subunit of acetylcholine receptors: Role of neuromuscular transmission
1989
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis
2010
Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy
2009
Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor–reactive T cells
1990
Microenvironment of thymic myoid cells in myasthenia gravis
1987
Polymyositis and dermatomyositis
2003 Standout
The synaptic vesicle cycle: a cascade of protein–protein interactions
1995 StandoutNatureNobel
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Guillain-Barré syndrome
2005 Standout
Cytoskeletal components of lymphoid organs
1987
Failure of anti‐GM1 IgG OR IgM to induce conduction block following intraneural transfer
1995
Myasthenia Gravis and its Animal Model: T Cell Receptor Expression in an Antibody Mediated Autoimmune Disease
1999
Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
1990
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
2008
Humoral factors in peripheral nerve disease
1987
Roles of protein and carbohydrate in glycoprotein processing and secretion. Studies using mutants expressing altered IgM mu chains.
1981 StandoutNobel
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
IgG from Patients with Lambert-Eaton Syndrome Blocks Voltage-Dependent Calcium Channels
1988 StandoutScienceNobel
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
1990 StandoutNobel
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.
1991 StandoutNobel
Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor t cells
1984
Active multi-subunit ACh receptor assembled by translation of heterologous mRNA in Xenopus oocytes
1981 StandoutNatureNobel
Expression of intermediate filament proteins during development of Xenopus laevis: II. Identification and molecular characterization of desmin
1989
An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis
1977
Analysis of Autoimmunity through Experimental Models of Thyroiditis and Allergic Encephalomyelitis
1980
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.
1996
Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia Gravis
1977
Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
1977
Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle.
1978
Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture.
1980
Comparative activities of tetanus and botulinum toxins
1984
The neuromuscular junction of the mouse after black widow spider venom.
1981
α-Latrotoxin and Its Receptors: Neurexins and CIRL/Latrophilins
2001 StandoutNobel
Neurotrophic regulation of two properties of skeletal muscle by impulse- dependent and spontaneous acetylcholine transmission
1982
Treatment of experimental myasthenia gravis with cyclosporin A
1985
Clostridial Neurotoxins: Handling and Action at the Cellular and Molecular Level
1986
Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junction
1983
Membrane Fusion and Exocytosis
1999 StandoutNobel
Effect of botulinum toxin on trophic regulation of acetycholine receptors
1976 Nature
Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis.
1982 StandoutNobel
Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells
1986 StandoutNatureNobel
Nicotinic acetylcholine receptors in vertebrate muscle: Properties, distribution and neural control
1985
XIF3, a Xenopus peripherin gene, requires an inductive signal for enhanced expression in anterior neural tissue
1989 StandoutNobel
Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome
2001
The Human Thymic Microenvironment
1984
Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
1984 StandoutNobel
The Intrinsic Electrophysiological Properties of Mammalian Neurons: Insights into Central Nervous System Function
1988 StandoutScience
Structure and Evolution of Neurexophilin
1996 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
Peptides and Autoimmune Disease
1978
Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses.
1991 StandoutNobel
Action of brown widow spider venom and botulinum toxin on the frog neuromuscular junction examined with the freeze‐fracture technique.
1977
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
1993 StandoutNobel
Relation between subsynaptic receptor blockade and response to quantal transmitter at the mouse neuromuscular junction.
1981
Passive transfer of the Lambert‐Eaton myasthenic syndrome: Neuromuscular transmission in mice injected with plasma
1985
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
In vitro synthesis, glycosylation, and membrane insertion of the four subunits of Torpedo acetylcholine receptor.
1981 StandoutNobel
Mechanisms of acetylcholine receptor loss in myasthenia gravis.
1980
Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.
1987
Direct Binding Studies of Adrenergic Receptors: Biochemical, Physiologic, and Clinical Implications
1979 StandoutNobel
Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors.
1979
Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia Gravis
1982
Hormonal regulation of membrane receptors and cell responsiveness: A review
1978
Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation
1978
Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin
1987
Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance
1999 StandoutNobel
Acetylcholinesterase mutants in drosophila and their effects on the structure and function of the cental nervous system
1980 StandoutNobel
Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies
1983
Hormone Receptors
1979
Effect of Myasthenic Immunoglobulin on Acetylcholine Receptors of Intact Mammalian Neuromuscular Junctions
1978 Science
Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors
1980 Nature
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
2011
Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications
2017
Botulinum A toxin and tetanus toxin do not affect presynaptic membrane currents in mammalian motor nerve endings
1983
Measurement of junctional acetylcholine receptors in myasthenia gravis: Clinical correlates
1985
Antibodies against low-density lipoprotein receptor–related protein 4 induce myasthenia gravis
2013
Prediction of protein antigenic determinants from amino acid sequences.
1981 Standout
Motor Nerve Sprouting and Acetylcholine Receptors
1978 Science
Works of Ing Kao being referenced
Thymic Muscle Cells Bear Acetylcholine Receptors: Possible Relation to Myasthenia Gravis
1977 Science
Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
1978
Myasthenia Gravis
1977
Myasthenia Gravis: Passive Transfer from Man to Mouse
1975 Science
Myasthenic Immunoglobulin Accelerates Acetylcholine Receptor Degradation
1977 Science
Botulinum Toxin: Mechanism of Presynaptic Blockade
1976 Science
MYASTHENIA GRAVIS AS A RECEPTOR DISORDER
1976